Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: new treatment for global dangers.
Ahmed
M H
MH
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D050171:Dyslipidemias / Q000139:chemically induced*; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
D005464:Fluorobenzenes; D008077:Lipoproteins, LDL; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium